An Editorial Archive
Treatment Guides
Long-form, unhurried readings of regenerative and aesthetic treatments at the Gangnam clinic quarter — what each procedure is, what it isn't, and the questions worth asking before the consultation room door closes.
Treatment Guide
Korean exosome treatment vs US clinics
What MFDS approves, what the FDA restricts, what the pricing differential reflects, and how to read the regulatory geography honestly.
Read article →Treatment Guide
Seoul stem cell pricing by district
What exosome and growth-factor protocols actually cost across Seoul's main clusters, in KRW, USD, CNY, JPY, and EUR.
Read article →Treatment Guide
Seoul stem cell districts compared
Gangnam, Cheongdam, Apgujeong, Sinsa, and Myeongdong — what each cluster actually does well, and what it does not.
Read article →Treatment Guide
Seoul stem cell aftercare protocol
How to manage the multi-day recovery window after exosome microneedling or growth-factor protocols, in Seoul and after flying home.
Read article →Treatment Guide
FDA and MFDS regulatory evidence frameworks, side by side
How two serious agencies read the same exosome bio-active class differently, what the evidence each weighs actually is, and what an American patient should understand before booking Seoul.
Read article →Treatment Guide
Korean exosome research in NIH PubMed
A reader's guide to the Seoul-origin publication trail — which groups, which journals, and how to read the literature honestly.
Read article →Treatment Guide
Reading the NIH clinical trials registry for exosome and stem cell adjunct work
What ClinicalTrials.gov registration actually signals, which trial categories are relevant to Seoul-style dermatologic and adjunct-wellness protocols, and how to read trial-status fields against active clinical practice.
Read article →Treatment Guide
Multi-trip exosome IV course protocols
How six-month, annual, and semi-annual return cadences are structured at senior Seoul practices, and what the trip-planning and cost arithmetic look like for international patients on a continuing…
Read article →Treatment Guide
Korean public research grants for regenerative medicine
How the KAIST, Seoul National University, and KIBO funding streams underwrite the basic-science and translational layer that eventually reaches the Seoul clinical bedside.
Read article →Treatment Guide
Exosome IV protocols across Seoul
How dosing, cadence, and biological source are structured at Seoul practices, and how the Korean regulatory frame shapes what is actually available at the bedside.
Read article →Treatment Guide
Stem cell and exosome evidence base
What the published literature supports, what it does not yet support, and how to read regenerative-dermatology citations honestly.
Read article →Treatment Guide
Exosome IV — mechanism of action deep dive
miRNA cargo, paracrine signalling, and the cell-biology depth that sits behind the clinical protocol.
Read article →Treatment Guide
Anti-aging protocols for women in their 40s
Exosome IV plus microneedling adjunct — how Seoul practices design the protocol, and what the realistic outcome bands look like.
Read article →